Lying as Business Strategy
Those of you who take The Wall Street Journal probably caught Wednesday’s story about the efforts of Abbott Laboratories, a pharmaceutical company, to sell more of a very lucrative AIDS drug. The challenge for Abbott was that one of their lower-margin drugs was widely used in conjunction with a competitor’s drug, in lieu of a …